UNSPSC 51183107: Glymidine sodium

This classification denotes an anti-diabetic agent with the molecular formula C13H14N3O4S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QPY3C057X1, chemically known as benzenesulfonamide, n-(5-(2-methoxyethoxy)-2-pyrimidinyl)-, sodium salt but more generally known as glymidine sodium, which bears US NIH Compound Identifier 18956. European Medicines Agency schedules Glymidine sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07954MIG.

UNSPSC 51183107 Glymidine sodium is a Commodity code covering pharmaceutical supply through state and local multistate cooperative purchasing agreements. State and local government procurement under this code focuses on establishing framework contracts with pharmaceutical manufacturers to supply generic drugs and over-the-counter products through authorized wholesaler networks to participating state agencies, counties, municipalities, and other public health facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body active under this code, operating purchasing vehicles that serve multiple states including Oregon and drawing participation from across state and local jurisdictions.

The Minnesota Department of Administration issued an RFP on January 20, 2026 (MMCAP S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026. Vendors supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and must comply with current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), FDA requirements, and maintain contractual relationships with at least two of the three wholesalers. Evaluation criteria weight price competitiveness at 75 percent, with fixed pricing, administrative fee format compliance, EDI capability, and administrative fee agreement each accounting for 5 to 10 percent. Products must be available by May 15, 2026, with awarded contracts effective July 1, 2026, and the contract term is two years for new vendors with optional MMCAP extensions. Vendors must carry commercial general liability insurance of $5,000,000 per occurrence and professional liability of $2,000,000, and will pay a 3 percent administrative fee on all purchases with performance penalties ranging from $200 to $1,500 per violation.